IntelliEPI Cayman Total Liabilities
IntelliEPI Cayman total liabilities. Based on the latest financial reports, IntelliEPI Cayman (4971) has total liabilities worth NT$206.96 Million TWD (≈ $6.52 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check IntelliEPI Cayman asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of IntelliEPI Cayman (2011–2025)
Total liabilities of IntelliEPI Cayman from 2011 to 2025. This chart illustrates how IntelliEPI Cayman's total liabilities have evolved over time, based on quarterly financial data. Explore IntelliEPI Cayman long-term investment intensity to see how much of total assets are deployed in long-term investments.
IntelliEPI Cayman Competitors by Total Liabilities
The table below lists competitors of IntelliEPI Cayman ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Electra Therapeutics, Inc. Common stock
NASDAQ:ETRA
|
USA | $133.27 Million |
|
LS Materials
KQ:417200
|
Korea | ₩85.47 Billion |
|
YungShin Global Holding Corp
TW:3705
|
Taiwan | NT$4.59 Billion |
|
Greenlight Capital Re Ltd
NASDAQ:GLRE
|
USA | $1.54 Billion |
|
Qualipoly Chemical Corp
TW:4722
|
Taiwan | NT$3.60 Billion |
|
Sinosun Tech
SHE:300333
|
China | CN¥13.94 Million |
|
Zaptec AS
OL:ZAP
|
Norway | Nkr425.90 Million |
|
Nagarro SE
XETRA:NA9
|
Germany | €587.94 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down IntelliEPI Cayman's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is IntelliEPI Cayman's balance sheet.
Liquidity & Leverage Metrics
IntelliEPI Cayman Total Liabilities Ratios Explained
IntelliEPI Cayman total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.44 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.09 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IntelliEPI Cayman's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IntelliEPI Cayman (2011–2025)
The table below shows the annual total liabilities of IntelliEPI Cayman from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$127.53 Million ≈ $4.02 Million |
-51.36% |
| 2024-12-31 | NT$262.17 Million ≈ $8.26 Million |
-9.85% |
| 2023-12-31 | NT$290.82 Million ≈ $9.16 Million |
+129.97% |
| 2022-12-31 | NT$126.46 Million ≈ $3.98 Million |
+13.03% |
| 2021-12-31 | NT$111.88 Million ≈ $3.52 Million |
+40.96% |
| 2020-12-31 | NT$79.37 Million ≈ $2.50 Million |
+10.22% |
| 2019-12-31 | NT$72.01 Million ≈ $2.27 Million |
-6.88% |
| 2018-12-31 | NT$77.33 Million ≈ $2.44 Million |
-12.82% |
| 2017-12-31 | NT$88.71 Million ≈ $2.79 Million |
-4.40% |
| 2016-12-31 | NT$92.78 Million ≈ $2.92 Million |
+15.02% |
| 2015-12-31 | NT$80.67 Million ≈ $2.54 Million |
-76.00% |
| 2014-12-31 | NT$336.11 Million ≈ $10.59 Million |
+506.25% |
| 2013-12-31 | NT$55.44 Million ≈ $1.75 Million |
+17.66% |
| 2012-12-31 | NT$47.12 Million ≈ $1.48 Million |
+7.55% |
| 2011-12-31 | NT$43.81 Million ≈ $1.38 Million |
-- |
About IntelliEPI Cayman
IntelliEPI Inc. (Cayman), together with its subsidiaries, produces and sells epitaxy wafers of compound semiconductor for use in wireless communications, data transmission and national defense in the United States, Germany, Korea, Japan, China, and internationally. The company utilizes its proprietary real-time in situ growth monitoring technology on molecular beam epitaxy (MBE) systems for the m… Read more